ANNE WADHAM: Open Payments
NPI 1821053984 · EUREKA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$57 in 4 payments from 3 companies in 2025. Trend: 2023 $231 · 2024 $389 · 2025 $57
Food & beverage: $57
| Company | Payments | Amount |
|---|---|---|
| Octapharma USA, Inc. | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Organon LLC | 2 | $12 |
Products named: FIBRYGA, MYFEMBREE, NEXPLANON.
Industry payments across CA — which companies pay providers there.
